所以，糖尿病患者在出现有不明原因的胃肠道症状时，需要提高警惕，尤其是老糖友，由于老人们的消化器官会随着年龄的增长而发生一定的退行性改变，胃肠道分泌和蠕动功能均会有不同程度的减退，同时病史较长，血糖控制不理想，血管及神经系统并发症较多，这些不利因素都可能会对胃肠道蠕动功能产生一定的不良影响，因此，当老友们出现有如饱胀、腹痛、呕吐时，应及时到医院检查，一旦确诊为因糖尿病而并发的胃轻瘫时，应积极配合医生的治疗。” 还说：“打了孩子，一是心疼孩子，二是后悔，生怕打孩子会在孩子的心里留下不良的阴影，” 循循善诱才是最佳的途径，很多家长百般无奈之下打孩子的屁股，为了让孩子长记性，吸取教训。 与整车龙头带动汽车产业发展一样，六大先进制造业中的新材料、智能电气等产业也在大企业大项目的带动下做强做大。” “直到12月6日车主发了微博，我们才知道车辆受损了。
IAN FRAZER, the developer of the HPV vaccine against cervical cancer, and his medical team will work with a local company to conduct clinical trials in Shenzhen, the Shenzhen Economic Daily reported yesterday.
The medical team led by the Scottish-born Australian immunologist, who is also the president of Cancer Council Australia, will officially sign deals with Shenzhen Dehui International Holdings within the year to carry out clinical trials on a new therapeutic HPV vaccine at the city’s international institute of translational medicine.
Frazer’s research on the vaccine against cervical cancer started in 1991. The academician and his Chinese fellow scientist Zhou Jian developed and patented the basic technology behind the HPV vaccine at the University of Queensland, Australia. It was the first vaccine designed to prevent a kind of cancer.
So far, more than 100 million people worldwide have received the quadrivalent HPV vaccine. This August, the nine-valent HPV vaccine became available on the Chinese mainland. Shenzhen also offered 1,060 inoculations and all of the appointments were booked on the first day reservation was available.
In Australia where the vaccine was invented, the government started offering free vaccinations for boys and girls below the age of 12 in 2007. According to a report released by the International Papillomavirus Society this year, the morbidity of cervical cancer among Australian women decreased from 20 percent to only 1 percent over the past 10 years.
However, the vaccination can only prevent cervical cancer and is not effective at treating patients already diagnosed with the cancer.
Public information shows that cervical cancer is still the cancer with the second-highest morbidity in China for women between the ages of 15 and 44. Each year, the nation sees an average of more than 130,000 new patients of cervical cancer, accounting for 28.8 percent globally. Approximately 80,000 Chinese women die of the cancer each year.
According to the Daily’s report, Frazer and his medical team is now working on treating cervical cancer patients by adopting immunological methods. The research has entered the stage of clinical trials, with further work to be carried out at the Shenzhen institute.